Researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons learnt from the severe acute respiratory syndrome coronavirus ...

The United Kingdom government plans to implement mass scale population testing for SARS-CoV-2 infection using Lateral Flow Devices (LFDs), yet the devices' sensitivity is unknown. A study ...

The AffiDX® SARS-CoV-2 antigen lateral flow test has been developed using Avacta’s proprietary Affimer® platform to identify individuals with a higher viral load of the SARS-CoV-2 virus who ...

A live video broadcast to Facebook about the methods used to sterilise medical equipment has falsely suggested “ethylene oxide-coated” swabs in lateral flow tests cause cancer. This claim ...

Lateral flow test kits, which can provide results in just 30 minutes, are now available free through workplaces, at testing sites and via the post. The further expansion of testing will enable the ...

However, a new study has found lateral flow tests are more accurate than previously reported and cannot be compared directly to how PCR tests work.

In a new study, researchers from Harvard University explored the benefits of different COVID-19 testing schemes with regards to the new Paxlovid drug.

With the role of testing only increasing in the future for infectious diseases beyond the current crisis, the teams at ams OSRAM and Jabil saw an opportunity to bring these lateral flow tests into ...

An artificial intelligence app to read COVID-19 lateral flow tests helped to reduce false results in a recent trial.

Biotech company Senzo just raised a $2 million round at a $20 million pre-money valuation to further extend options for lateral flow diagnostics.

Accessible Lateral Flow Assays: Test to Treat, Test to Protect From development to implementation, Rosanna Peeling discusses the importance of rapid tests for public health.